Cytokinetics
CYTK
$48.51
Share price
-1.24%
Change (1 day)
27.79%
Change (1 year)
Categories
Cytokinetics (CYTK) - Cash on Hand
Cash on Hand as of March 2024 : $0.61 B
According to Cytokinetics
's latest financial reports the company has $0.61 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Cytokinetics - Cash on Hand chart (from 2003 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.61 B | -21.44% |
| 2022-12-31 | $0.78 B | 65.93% |
| 2021-12-31 | $0.47 B | 1.63% |
| 2020-12-31 | $0.46 B | 106.15% |
| 2019-12-31 | $0.22 B | 13.27% |
| 2018-12-31 | $0.19 B | -26.09% |
| 2017-12-31 | $0.26 B | 72.09% |
| 2016-12-31 | $0.15 B | 40.21% |
| 2015-12-31 | $0.11 B | 33.9% |
| 2014-12-31 | $83.22 M | 7.08% |
| 2013-12-31 | $77.72 M | 5.04% |
| 2012-12-31 | $74 M | 50.95% |
| 2011-12-31 | $49.02 M | -31.57% |
| 2010-12-31 | $71.63 M | -37.56% |
| 2009-12-31 | $0.11 B | 101.75% |
| 2008-12-31 | $56.86 M | -52.51% |
| 2007-12-31 | $0.11 B | 9.31% |
| 2006-12-31 | $0.10 B | 43.73% |
| 2005-12-31 | $76.21 M | -27.9% |
| 2004-12-31 | $0.10 B | 200.38% |
| 2003-12-31 | $35.18 M | 31.23% |
| 2002-12-31 | $26.81 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $9.70 B | 1,468.43% | 🇺🇸 USA |
 Trevena TRVN | $23.55 M | -96.19% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | $0.31 B | -49.82% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $9.36 M | -98.49% | 🇺🇸 USA |
 Array Technologies ARRY | $0.28 B | -53.53% | 🇺🇸 USA |